MarketWatch: Health Round-up

Published by: Datamonitor

Published: Feb. 17, 2009 - 31 Pages

Table of Contents

In this month's MarketWatch…

Pharmaceutical Company Round-up

Cancer Update

- News Round-up

- Feature Analysis: Merck & Co: US setback for Gardasil use in older women

- Opinion: Novartis: Afinitor advances in breast cancer trials

Cardiovascular Update

- News Round-up

Central Nervous System Update

- News Round-up

- Feature Analysis: Ovation Pharmaceuticals' Sabril recommended by FDA panel despite reports of visual field defect

- Opinion: Transcept: Intermezzo accepted for review by the FDA

- Opinion: Eli Lilly: further Zyprexa Adhera delays benefit Johnson & Johnson

IDI Update

- News Round-up

- Opinion: UCB: Cimzia's indication expansion hindered by FDA

Infectious Diseases Update

- News Round-up

- Opinion: AstraZeneca: nasal flu vaccine submitted for European approval

Industry Update

- Opinion: Schering-Plough: new infertility drug only partially addresses unmet need

- Feature Analysis: Pharmacy liberalization on hold: a sign of things to come?

Company Spotlight

- Wyeth

Biotechnology Update

- News Round-up

- Opinion: AstraZeneca: nasal flu vaccine submitted for European approval

- Opinion: Wyeth: Big Pharma continues its shopping spree

Biotechnology Company Spotlight

- Novo Nordisk

Further Reading

Index

- Pharma companies

- Biotech companies

- Key drugs

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.